These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 25392716)
21. Prediction of supertype-specific HLA class I binding peptides using support vector machines. Zhang GL; Bozic I; Kwoh CK; August JT; Brusic V J Immunol Methods; 2007 Mar; 320(1-2):143-54. PubMed ID: 17303158 [TBL] [Abstract][Full Text] [Related]
22. Application of machine learning techniques in predicting MHC binders. Lata S; Bhasin M; Raghava GP Methods Mol Biol; 2007; 409():201-15. PubMed ID: 18450002 [TBL] [Abstract][Full Text] [Related]
23. Is there MHC Class II restriction of the response to MHC Class I in transplant patients? Papassavas AC; Barnardo MC; Bunce M; Welsh KI Transplantation; 2002 Feb; 73(4):642-51. PubMed ID: 11889447 [TBL] [Abstract][Full Text] [Related]
24. Improved prediction of MHC class I binders/non-binders peptides through artificial neural network using variable learning rate: SARS corona virus, a case study. Soam SS; Bhasker B; Mishra BN Adv Exp Med Biol; 2011; 696():223-9. PubMed ID: 21431562 [TBL] [Abstract][Full Text] [Related]
25. Major histocompatibility complex linked databases and prediction tools for designing vaccines. Singh SP; Mishra BN Hum Immunol; 2016 Mar; 77(3):295-306. PubMed ID: 26585361 [TBL] [Abstract][Full Text] [Related]
26. POPI: predicting immunogenicity of MHC class I binding peptides by mining informative physicochemical properties. Tung CW; Ho SY Bioinformatics; 2007 Apr; 23(8):942-9. PubMed ID: 17384427 [TBL] [Abstract][Full Text] [Related]
27. Characterizing immunodominant and protective influenza hemagglutinin epitopes by functional activity and relative binding to major histocompatibility complex class II sites. Rajnavölgyi E; Horváth A; Gogolák P; Tóth GK; Fazekas G; Fridkin M; Pecht I Eur J Immunol; 1997 Dec; 27(12):3105-14. PubMed ID: 9464794 [TBL] [Abstract][Full Text] [Related]
28. Prediction of peptides binding to MHC class I and II alleles by temporal motif mining. Meydan C; Otu HH; Sezerman OU BMC Bioinformatics; 2013; 14 Suppl 2(Suppl 2):S13. PubMed ID: 23368521 [TBL] [Abstract][Full Text] [Related]
29. Accurate pan-specific prediction of peptide-MHC class II binding affinity with improved binding core identification. Andreatta M; Karosiene E; Rasmussen M; Stryhn A; Buus S; Nielsen M Immunogenetics; 2015 Nov; 67(11-12):641-50. PubMed ID: 26416257 [TBL] [Abstract][Full Text] [Related]
30. USMPep: universal sequence models for major histocompatibility complex binding affinity prediction. Vielhaben J; Wenzel M; Samek W; Strodthoff N BMC Bioinformatics; 2020 Jul; 21(1):279. PubMed ID: 32615972 [TBL] [Abstract][Full Text] [Related]
31. Modeling alternative binding registers of a minimal immunogenic peptide on two class II major histocompatibility complex (MHC II) molecules predicts polarized T-cell receptor (TCR) contact positions. Murray JS; Fois SD; Schountz T; Ford SR; Tawde MD; Brown JC; Siahaan TJ J Pept Res; 2002 Mar; 59(3):115-22. PubMed ID: 11985705 [TBL] [Abstract][Full Text] [Related]
32. Application of support vector machines for T-cell epitopes prediction. Zhao Y; Pinilla C; Valmori D; Martin R; Simon R Bioinformatics; 2003 Oct; 19(15):1978-84. PubMed ID: 14555632 [TBL] [Abstract][Full Text] [Related]
33. Structure-based identification of MHC binding peptides: Benchmarking of prediction accuracy. Kumar N; Mohanty D Mol Biosyst; 2010 Dec; 6(12):2508-20. PubMed ID: 20953500 [TBL] [Abstract][Full Text] [Related]
34. Prediction of MHC class I binding peptides using profile motifs. Reche PA; Glutting JP; Reinherz EL Hum Immunol; 2002 Sep; 63(9):701-9. PubMed ID: 12175724 [TBL] [Abstract][Full Text] [Related]
35. An immunoinformatics-derived DNA vaccine encoding human class II T cell epitopes of Ebola virus, Sudan virus, and Venezuelan equine encephalitis virus is immunogenic in HLA transgenic mice. Bounds CE; Terry FE; Moise L; Hannaman D; Martin WD; De Groot AS; Suschak JJ; Dupuy LC; Schmaljohn CS Hum Vaccin Immunother; 2017 Dec; 13(12):2824-2836. PubMed ID: 28575582 [TBL] [Abstract][Full Text] [Related]
36. Footprints of antigen processing boost MHC class II natural ligand predictions. Barra C; Alvarez B; Paul S; Sette A; Peters B; Andreatta M; Buus S; Nielsen M Genome Med; 2018 Nov; 10(1):84. PubMed ID: 30446001 [TBL] [Abstract][Full Text] [Related]
37. Similarity between segments in protein conformational epitopes and MHC II peptides. Li G; Wu D; Wang S; Sun J; Xu D; Cao Z Int J Comput Biol Drug Des; 2013; 6(1-2):107-18. PubMed ID: 23428477 [TBL] [Abstract][Full Text] [Related]
38. Expression mapping using a retroviral vector for CD8+ T cell epitopes: definition of a Mycobacterium tuberculosis peptide presented by H2-Dd. Aoshi T; Suzuki M; Uchijima M; Nagata T; Koide Y J Immunol Methods; 2005 Mar; 298(1-2):21-34. PubMed ID: 15847794 [TBL] [Abstract][Full Text] [Related]
39. Toward the prediction of class I and II mouse major histocompatibility complex-peptide-binding affinity: in silico bioinformatic step-by-step guide using quantitative structure-activity relationships. Hattotuwagama CK; Doytchinova IA; Flower DR Methods Mol Biol; 2007; 409():227-45. PubMed ID: 18450004 [TBL] [Abstract][Full Text] [Related]
40. Development and validation of a broad scheme for prediction of HLA class II restricted T cell epitopes. Paul S; Lindestam Arlehamn CS; Scriba TJ; Dillon MB; Oseroff C; Hinz D; McKinney DM; Carrasco Pro S; Sidney J; Peters B; Sette A J Immunol Methods; 2015 Jul; 422():28-34. PubMed ID: 25862607 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]